ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 84 filers reported holding ADICET BIO INC in Q3 2023. The put-call ratio across all filers is 7.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $927 | +81.4% | 677,000 | +221.8% | 0.00% | +100.0% |
| Q2 2023 | $511 | -71.9% | 210,403 | -33.4% | 0.00% | -50.0% |
| Q1 2023 | $1,819 | +583.8% | 315,800 | +963.3% | 0.00% | – |
| Q4 2022 | $266 | -100.0% | 29,700 | -76.3% | 0.00% | -100.0% |
| Q2 2022 | $1,832,000 | +453.5% | 125,500 | +197.3% | 0.00% | – |
| Q3 2021 | $331,000 | -60.6% | 42,217 | -48.3% | 0.00% | -100.0% |
| Q2 2021 | $841,000 | +219.8% | 81,700 | +306.5% | 0.00% | – |
| Q1 2021 | $263,000 | – | 20,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |